CG
LRMR icon

Cutler Group’s Larimar Therapeutics LRMR Stock Holding History

Cutler Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,508
Closed -$1K – 6843
2016
Q4 		$1K Hold
1,508
– – ﹤0.01% 6042
2016
Q3 		$4K Buy
1,508
+1,333
+762% +$60.5K ﹤0.01% 5154
2016
Q2 		$8K Sell
175
-408
-70% -$32.2K ﹤0.01% 4431
2016
Q1 		$12K Sell
583
-234
-29% -$18.5K ﹤0.01% 3853
2015
Q4 		$47K Buy
+817
New +$131K ﹤0.01% 2528

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return